| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chf Clinical Develop Ofcr
1 company
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2024-02-02 | IONS | EVP, Chf Clinical Develop Ofcr | Sell | 2,071 | $49.59 | $102,700.89 | -4.0% | → |
| 2024-01-17 | IONS | EVP, Chf Clinical Develop Ofcr | Sale+OE | 5,482 | $50.42 | $276,385.99 | -10.3% | → |
| 2024-01-12 | IONS | EVP, Chf Clinical Develop Ofcr | Sale+OE | 8,000 | $53.50 | $427,999.20 | -17.3% | → |
| 2023-12-26 | IONS | EVP, Chf Clinical Develop Ofcr | Sale+OE | 25,000 | $51.46 | $1,286,575.00 | -40.9% | → |
| 2023-02-06 | IONS | EVP, Chf Clinical Develop Ofcr | Sell | 1,413 | $40.67 | $57,464.17 | -5.4% | → |
| 2023-01-18 | IONS | EVP, Chf Clinical Develop Ofcr | Sale+OE | 4,752 | $39.57 | $188,051.85 | -17.5% | → |